Name: Latest research reports of Alkem Laboratories Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Alkem Laboratories Ltd.
Rating: 3
Author: BOB Capital Markets Ltd.

Alkem Laboratories Ltd.

NSE: ALKEM | BSE: 539523 | ISIN: INE540L01014 | Industry: Pharmaceuticals
| Strong Performer, Getting Expensive

5495.0000 -46.50 (-0.84%)

NSE Sep 22, 2025 15:31 PM

Volume: 382.5K

High volume today

Alkem Laboratories Ltd.

08 Nov 2023

5495.00

-0.84%

Alkem Labs (HOLD): Sizeable margin gains; tax guided to reduce raise to HOLD

Hold: Alkem Laboratories Ltd.

Recommendation Target

BOB Capital Markets Ltd.

Q2 EBITDA/PAT outstripped consensus by 44%/54% on higher margins, strong US growth and low taxes

ICICI Securities Limited increased Buy price target of Alkem Laboratories Ltd. to 6400.0 on 19 Sep, 2025.